Oct. 18, 2021– A new federal government report could add momentum to efforts on Capitol Hill to end limitations on 340B price discounts for orphan drugs purchased by certain safety-net hospitals. The report suggests that drug companies might be seeking orphan status for their products to maximize revenues and avoid paying 340B discounts on drugs widely used to treat common … [Read more...]
Bipartisan Congressional Calls to Protect 340B Intensify
Aug. 4, 2021– A pair of lawmakers is working to advance the latest example of bipartisan, pro-340B legislation in Congress. Reps. Abigail Spanberger (D-Va.) and David McKinley (R-W.V.) recently introduced the Preserving Rules Ordered for The Entities Covered Through 340B Act, also known as the PROTECT 340B Act, and are gathering cosponsors from both sides of the political … [Read more...]
Members of Congress Aim to Drum up Support for 340B
May 16, 2018—Two stalwart supporters of the 340B program in Congress appealed today for more help engaging lawmakers and more of the public in efforts to protect the drug discount program. Reps. David McKinley (R-W.V.) and Doris Matsui (D-Calif.) spoke at a May 16 Capitol Hill briefing sponsored by Vizient, a healthcare services company that contracts with 340B hospitals … [Read more...]
340B Hospitals Will Ask Appeals Court to Stop Harmful Medicare Part B Cuts
January 12, 2018—Three national hospital groups and three local health systems will appeal a federal district judge’s dismissal of their lawsuit aimed at stopping a nearly 30 percent cut in 340B disproportionate share hospitals’ (DSH) and rural referral centers’ (RRC) Medicare Part B drug reimbursement that took effect on Jan. 1. On Jan. 9, the groups and systems formally … [Read more...]